Aplastic anemia following hepatitis associated with human herpesvirus 6

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 4, 2010, Pages 527-529

  Schenke, Carolus ^a   Alejandre Alcázar, Miguel A ^a   Holter, Wolfgang ^a   Korn, Klaus ^b   Papadopoulos, Thomas ^c   Köhler, Henrik ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Institute for Clinical and Molecular Virology   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIBODY; PREDNISOLONE; THYMOCYTE ANTIBODY; VIRUS DNA;

ACUTE HEPATITIS; ANOREXIA; APLASTIC ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILD; CHOLESTASIS; DISEASE ASSOCIATION; HEPATOMEGALY; HISTOLOGY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; LETHARGY; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER NECROSIS; LYMPHOCYTIC INFILTRATION; MALE; PANCYTOPENIA; PETECHIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN BLEEDING;

ANEMIA, APLASTIC; ANTI-INFLAMMATORY AGENTS; ANTILYMPHOCYTE SERUM; BIOPSY; CHILD, PRESCHOOL; CYCLOSPORINE; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEPATITIS, VIRAL, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER FUNCTION TESTS; MALE; PREDNISOLONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROSEOLOVIRUS INFECTIONS;

HUMAN HERPESVIRUS 6;

EID: 78449239388     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181e9636e     Document Type: Article

References (36)

1. Brown KE, Tisdale J, Barrett AJ, et al. Hepatitis-associated aplastic anemia. N Engl J Med 1997;336:1059-64.
2. Pikis A, Kavaliotis J, Manios S. Incidence of aplastic anaemia in viral hepatitis in children. Scand J Infect Dis 1988;20:109-10.
3. Storb R, Longton G, Anasetti C, et al. Changing trend in marrow transplantation for aplastic anemia. Bone Marrow Transplant 1992; 10:45-52.
4. Speck B, Gluckman E, Haak HL, et al. Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusion. Lancet 1977;2:1145-8.
5. Bacigalupo A, Brand R, Oneto R, et al. Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy-the European Group for Blood and Marrow Transplantation experience. Semin Hematol 2000;37:69-80.
6. Ades L, Mary JY, Robin M, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 2004;103:2490-7.
7. Safadi R, Or R, Ilan Y, et al. Lack of known hepatitis virus in hepatitisassociated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant 2001;27:183-90.
8. Linet MS, Markowitz JA, Sensenbrenner LL, et al. A case-control study of aplastic anemia. Leuk Res 1989;13:3-11.
9. Issaragrisil S, Sriratanasatavorn C, Piankijagum A, et al. Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group. Blood 1991;77:2166-8.
10. Smith D, Gribble TJ, Yeager AS, et al. Spontaneous resolution of severe aplastic anemia associated with viral hepatitis A in a 6-year-old child. Am J Hematol 1978;5:247-52.
11. Kindmark CO, Sjölin J, Nordlinder H, et al. Aplastic anaemia in a case of hepatitis B with a high titer of hepatitis B antigen. Acta Med Scand 1984;215:89-92.
12. Langnas AN, Markin RS, Cattral MS, et al. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 1995;22:1661-5.
13. Pardi DS, Romero Y, Mertz LE, et al. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: A report of two cases and a review of the literature. Am J Gastroenterol 1998;93:468-70.
14. Imai T, Itoh S, Okada H, et al. Aplastic anemia following hepatitis associated with echovirus 3. Pediatr Int 2002;44:522-4.
15. Tzakis AG, Arditi M, Whitington PF, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med 1988;319:393-6.
16. Cattral MS, Langnas AN, Markin RS, et al. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology 1994;20:813-8.
17. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988;1:1065-7.
18. Pruksananonda P, Hall CB, Insel RA, et al. Primary human herpesvirus 6 infection in young children. N Engl J Med 1992;326:1445-50.
19. Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994;331:432-8.
20. Briggs M, Fox J, Tedder RS. Age prevalence of antibody to human herpesvirus 6. Lancet 1988;1:1058-9.
21. Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352:768-76.
22. Prezioso PJ, Cangiarella J, Lee M, et al. Fatal disseminated infection with human herpesvirus-6. J Pediatr 1992;120:921-3.
23. Asano Y, Yoshikawa T, Kajita Y, et al. Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child 1992;67:1484-5.
24. Dubedat S, Kappagoda N. Hepatitis due to human herpesvirus-6. Lancet 1989;2:1463-4.
25. Asano Y, Yoshikawa T, Suga S, et al. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 1990;335:862-3.
26. Tajiri H, Nose O, Baba K, et al. Human herpesvirus-6 infection with liver injury in neonatal hepatitis. Lancet 1990;335:863.
27. Sobue R, Miyazaki H, Okamoto M, et al. Fulminant hepatitis in primary human herpesvirus-6 infection. N Engl J Med 1991;324: 1290.
28. Cacheux W, Carbonell N, Rosmorduc O, et al. HHV-6-related acute liver failure in two immunocompetent adults: Favourable outcome after liver transplantation and/or ganciclovir therapy. J Intern Med 2005;258:573-8.
29. Härmä M, Höckerstedt K, Lautenschlager I. Human herpesvirus-6 and acute liver failure. Transplantation 2003;76:536-9.
30. Chevret L, Boutolleau D, Halimi-Idri N, et al. Human herpesvirus-6 infection: A prospective study evaluating HHV-6 DNA levels in liver from children with acute liver failure. J Med Virol 2008;80:1051-7.
31. Cermelli C, Concari M, Carubbi F, et al. Growth of human herpesvirus 6 in HEPG2 cells. Virus Res 1996;45:75-85.
32. Drobyski WR, Dunne WM, Burd EM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: Evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993;167:735-9.
33. Carrigan DR, Knox KK. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood 1994;84:3307-10.
34. Singh N, Carrigan DR, Gayowski T, et al. Human herpesvirus-6 infection in liver transplant recipients: Documentation of pathogenicity. Transplantation 1997;64:674-8.
35. Dockrell DH, Smith TF, Paya CV. Human herpesvirus 6. Mayo Clin Proc 1999;74:163-70.
36. Secchiero P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995;171:273-80.